We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Covington & Burling LLP is well-equipped to handle various high-value, cross-border transactions including public and private M&A on both the buy- and sell-side, divestitures, and disposals, as well as carve-outs and joint ventures. With a broad scope and international capabilities, the group is sought after by notable names from the life sciences, financial services, and energy sectors, including the likes of AstraZeneca. Leading the corporate practice is the ‘pragmatic and commercial’ Gregor Frizzell, who is adept at advising on multijurisdictional M&A and joint ventures. He is supported by takeover expert Phil Cheveley — who joined from Sidley Austin LLP in December 2024 — and life sciences authority Louise Nash. Other key members of the team include Lyndsey Laverack, Brandon Thompson, and Camilla Rogers.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The London M&A team delivered on a fast-paced transaction with some regulatory complexity.’
‘Gregor Frizzell led our deal on the M&A side and did a great job. He is pragmatic and commercial, and has strong supervision of the team.’
Key clients
- AstraZeneca
- Embracer Group AB
Work highlights
Represented Embracer Group in its divestiture of the operative group Easybrain to Miniclip.